Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s stock price traded down 0.1% during mid-day trading on Wednesday . The company traded as low as $4.1880 and last traded at $4.1880. 5,500 shares were traded during mid-day trading, an increase of 7% from the average session volume of 5,117 shares. The stock had previously closed at $4.1920.
Knight Therapeutics Stock Down 0.1%
The company has a 50 day moving average of $4.32 and a 200 day moving average of $4.40.
About Knight Therapeutics
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.
Read More
- Five stocks we like better than Knight Therapeutics
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
